5-Azacytidine treatment inhibits the development of lung cancer models via epigenetic reprogramming and activation of cellular pathways with anti-tumor activity. (2024). Medicine and Pharmacy Reports, 97(4), 488-506. https://doi.org/10.15386/mpr-2777